Transforming care by enabling world-class clinical trials
One point of contact for sponsors, and specialist trial administration for over 35 member hospitals and research institutes across Australia and New Zealand.
Which best describes you?
Sponsor or CRO
Run your study through one coordinated network, from first-in-human feasibility to close-out.
Hospital or Research Organisation
Join the network, or use CTA’s trial administration services at your site. See who is already part of it.
Patient or Carer
CTA doesn’t enrol patients directly, but we can point you to trusted places to start.
Researcher, Media or Partner
Annual reports, the Victorian census, dashboards and the latest news from the network.
Specialist trial administration, so sites can focus on patients
From the first feasibility enquiry to final close-out, CTA’s team manages the work that sits around every clinical trial.
Feasibility Evaluation
A single, coordinated First Time in Human feasibility review across the network, with advice on matching the right sites to your study.
Early Phase Trials
Access to CTA’s Phase I Group: the sites that conduct the majority of Phase I cancer trials in Australia.
Ethics & Governance Start-Up
Submissions prepared to meet requirements first time, maximising quality and minimising time to approval.
Budgets & Contracts
Trial budgets and contracts compiled and negotiated, supporting the financial sustainability of member trial units.
Post-Approval Management
Amendments and ongoing ethics and governance activities handled quickly as trials progress.
Finance & Trial Systems
Per-patient fees tracked and invoiced, plus a hosted Clinical Trial Management System for scheduling visits and procedures.
Numbers you can check in our own reports
Source: CTA Annual Report 2025
Source: CTA Annual Report 2024
Source: Current members
From feasibility to close-out
CTA can manage the full trial lifecycle for a site, or take on specific activities on a fee-for-service basis.
Feasibility
One coordinated review across the network.
Ethics & Governance
Submissions prepared to get it right first time.
Budgets & Contracts
Compiled and negotiated for you.
Post-Approval
Amendments and responses handled quickly.
Billing & Close-Out
Fees tracked, invoiced and closed out.
A not-for-profit network, governed by its members
Cancer Trials Australia grew out of the Centre for Developmental Cancer Therapies, formed in 1993 by a small group of medical oncologists, and was incorporated in 2003. Today it is a member-based organisation of clinical sites and research institutes across Australia and New Zealand.
We are a Board of directors made up of member-institution representatives and independent directors, with a shared vision to improve patient care by enabling the world’s best clinical trials.
Latest news from the Board
-
Twenty-thousand reasons for change
As we approach the recruitment of the 20,000th clinical trial participant, five leaders within our partnership network talk about their journey with Cancer Trials Australia (CTA) and how clinical trials…
-
Annual Victorian Cancer Clinical Trials Census 2022-2025
We are pleased to share with you our second Annual Victorian Cancer Clinical Trials Census report, Trends in Victorian cancer clinical trials participation 2022–2025 supported by the Victorian Government through the…
-
Reflections from Departing CTA Chairperson Professor Jayesh Desai, and Incoming CTA Chairperson Dr Dishan Herath
In line with CTA’s constitution, the CTA Board Chairperson was recently renewed. Here, outgoing Chairperson Professor Jayesh Desai and incoming Chairperson Dr Dishan Herath share their reflections on an organisation…
-
Cancer Trials Australia Annual Report 2025
I am pleased to share with you our 2025 Annual Report, released at our recent Annual General Meeting on 25 May, 2026. Please click here to access the report. In…
-
Maximising rare cancer clinical trials
Patients diagnosed with rare cancers often face poor survival outcomes and experience limited access to effective therapies, making clinical trials potentially the only viable treatment option. To help ensure Australian…
-
Cancer Trials Australia Annual Report 2024
I am pleased to share with you our 2024 Annual Report, released at our recent Annual General Meeting on 21 May, 2025. Please click here to access the report. After substantial membership…
Tell us what you’re working on
Whether you’re a sponsor planning a study in Australia or an organisation considering membership, our team will point you in the right direction.
